Video, 17 mins
Revolutionising Vaccine Safety Without Animal Testing
Ethical concerns surrounding animal research have prompted a need for alternative methods to be developed.
Part of Commercialisation Conversations
1 Oct 2024 13:00
Led by researchers at the University of Sheffield, Sansanima has created a technology that replaces animal research in the manufacturing of clostridial neurotoxin-based medical products.
The new technology will prevent animals from being used to quality control major global medicines like the tetanus vaccine.
Credits
Project Leads
- Professor Bazbek Davletov, Chair in Biomedical Science at The University of Sheffield
- Professor Andrew Peden, Professor at The University of Sheffield
- Ciara Doran, Director at Sansanima
- Richard Senior, Operations Director at Sansanima
